Please select the option that best describes you:

When testing for patients with symptoms of MPN, do you prefer to do JAK2 cascade testing or a leukemia NGS testing panel?   

As the cost of NGS decreases over time, is there still a need for more focused/targeted panels such as JAK2, CALR, and MPL? Are other genes important to find in case the patient may have CCUS? 



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Academic Institution
Sign in or Register to read more